A major barrier to translational research can be sourcing support and funding to develop and progress innovative ideas. For example, a researcher may spend three to five years obtaining seed funding to get their research project off the ground - and by then an offshore competitor may have beaten them to the opportunity. 

To support researchers to progress their discoveries and translate their findings into the clinic, TRI offers two Grant schemes: Spore and Drive Grants

SPORE Grants

The TRI Specialised Programs of Research Excellence (SPORE) Grants encourage multidisciplinary teams of scientists and clinicians from a combination of academic, commercial and clinical backgrounds to test innovative ideas. These teams are united by a a common goal to drive innovations into the clinic, towards improved health and commercial outcomes. 

To date TRI has awarded eight Spore Grants to support researchers at TRI to progress their innovative ideas. These Grants fund projects for up to 12 months, up to a possible total of $90,000 per Grant.

The next round of Spore Grants will open in April 2019.

Drive Grants

The TRI Drive Grant is an initiative of TRI which aims to accelerate translation of innovations into the clinic, bringing together multidisciplinary teams of scientists, clinicians and commercial partners to address an unmet clinical need. 

This Grant will support research projects that are beyond proof-of-concept stage, address an important clinical question, and have a defined translational outcome.

Applications for the first TRI Drive Grant will open in April 2019. Stay tuned for more details!